FDA warns on antidepressant use
http://www.100md.com
《英国医生杂志》
The Food and Drug Administration has requested a warning statement on the labels of certain antidepressants to encourage close observation of adult and paediatric patients who are being treated with these agents for worsening depression or the emergence of suicidal thoughts.
The drugs that are the focus of this new warning statement include fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, escitalopram, bupropion, venlafaxine, nefazodone, and mirtazapine.(BMJ Annabel Ferriman)
The drugs that are the focus of this new warning statement include fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, escitalopram, bupropion, venlafaxine, nefazodone, and mirtazapine.(BMJ Annabel Ferriman)